News and Trends 18 Jul 2022
First-ever Marketing Authorization Application for biosimilar targeting MS filed
An international biotech, with headquarters in Amsterdam, has announced that the European Medicines Agency (EMA) has accepted the first-ever Marketing Authorization Application (MAA) for its biosimilar product. Polpharma Biologics, which…